• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by VivoPower PLC

    7/17/26 5:25:01 PM ET
    $VIVO
    Power Generation
    Utilities
    Get the next $VIVO alert in real time by email
    6-K 1 form6-k.htm 6-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    Report of Foreign Private Issuer

    Pursuant to Rule 13a-16 or 15d-16

    under the Securities Exchange Act of 1934

     

    July 17, 2026

     

    Commission File Number 001-37974

     

    VIVOPOWER PLC

    (Translation of registrant’s name into English)

     

    Suite 4, 7th Floor, 50 Broadway,

    London, United Kingdom,

    SW1H 0DB

    +44-203-667-5158

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

     

    Form 20- F ☒ Form 40-F ☐

     

     

     

     
     

     

    Advisory Council Update

     

    On July 17, 2026, VivoPower PLC (“VivoPower” or the “Company”) announced that Mr. Adam Traidman will be concluding his role as Chairman of the Company’s Board of Advisors.

     

    Mr. Traidman joined the Company’s Board of Advisors as Chairman in May 2025, in connection with the Company’s capital raise and the launch of its digital asset treasury strategy. A former board member of Ripple and co-founder of several blockchain ventures, he was engaged to advise on matters relating to digital assets, blockchain technology and the XRP Ledger ecosystem.

     

    As the Company’s focus has increasingly centered on the development and scaling of its powered land and data center digital infrastructure, with operations spanning Norway, Finland and the United Arab Emirates, the Company and Mr. Traidman have mutually agreed that this is a natural point to conclude his advisory engagement.

     

    The Company would like to thank Mr. Traidman for his contributions and confirms that his departure did not result from any disagreement with the Company on any matter relating to its operations, policies or practices and should it be relevant and appropriate in future, would look forward to engaging with Mr. Traidman again.

     

    This Report on Form 6-K, is hereby incorporated by reference into the Company’s Registration Statements on Form S-8 (File Nos. 333-227810, 333-251546, 333-268720, 333-273520) and Form F-3 (File No. 333-292437).

     

    Forward-Looking Statements

     

    This communication includes certain statements that may constitute “forward-looking statements” for purposes of the U.S. federal securities laws. Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements may include, for example, statements about the Company’s ability to execute on its AI infrastructure strategy, the proposed business combination of the Company’s Tembo subsidiary, and the benefits of the events or transactions described in this communication. These statements are based on VivoPower’s management’s current expectations or beliefs and are subject to risk, uncertainty, and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to changes in economic, business, competitive and/or regulatory factors, and other risks and uncertainties affecting the operation of VivoPower’s business. These risks, uncertainties and contingencies include changes in business conditions, fluctuations in customer demand, changes in accounting interpretations, management of rapid growth, intensity of competition from other providers of products and services, changes in general economic conditions, geopolitical events and regulatory changes, and other factors set forth in VivoPower’s filings with the United States Securities and Exchange Commission. The information set forth herein should be read in light of such risks. VivoPower is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements whether as a result of new information, future events, changes in assumptions or otherwise.

     

     
     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: July 17, 2026 VivoPower PLC
       
      /s/ Kevin Chin
      Kevin Chin
      Executive Chairman

     

     

    Get the next $VIVO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VIVO

    DatePrice TargetRatingAnalyst
    2/7/2022$28.00 → $30.00Buy
    HC Wainwright & Co.
    11/15/2021$27.00 → $28.00Buy
    HC Wainwright & Co.
    8/9/2021$30.00 → $27.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $VIVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Jeavons Peter

    3 - VivoPower PLC (0001681348) (Issuer)

    4/8/26 8:54:33 AM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form 4: Williams Felicia returned 10,274 shares to the company, closing all direct ownership in the company

    4 - MERIDIAN BIOSCIENCE INC (0000794172) (Issuer)

    1/31/23 2:22:23 PM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form 4: Sazdanoff Catherine returned 16,424 shares to the company, closing all direct ownership in the company

    4 - MERIDIAN BIOSCIENCE INC (0000794172) (Issuer)

    1/31/23 2:21:33 PM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VivoPower Appoints Group Finance Director

    LONDON, UK / ABU DHABI, UAE, July 20, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today announced the appointment of Syed Muhammad Nouman, FCA, as Group Finance Director, effective from July 20, 2026. Mr. Nouman will serve as the Company’s Principal Financial Officer and Principal Accounting Officer for SEC reporting purposes, as ratified by the Company’s Audit Committee. Mr. Nouman began his career at PwC, where he developed a strong foundation in audit and financial reporting. He is a Fellow Chartered Accountant (FCA) with mor

    7/20/26 9:00:00 AM ET
    $VIVO
    Power Generation
    Utilities

    Noble Capital Markets Initiates Equity Research Coverage on VivoPower

    LONDON, UK / OSLO, NORWAY, July 13, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, is pleased to announce that Noble Capital Markets has initiated company-sponsored equity research coverage on the Company with an Outperform rating and a $10.00 price target. The research report, authored by Noble Capital Markets Senior Research Analyst Michael Kupinski, is available on Channelchek, along with the latest news, market data, and additional information on Tectonic. Management encourages investors to review the report and visit Channelc

    7/13/26 1:00:00 PM ET
    $VIVO
    Power Generation
    Utilities

    VivoPower Targets Up To USD$4 million Incremental Annualized EBITDA from Battery Energy Storage Integration at Norway Data Center

    BESS integration targeted to unlock additional FCR-N, FCR-D and FFR Grid Reserve revenue streams  Design would preserve the site's full leasable capacity for AI compute tenants Final investment decision subject to board approval, post completion of external feasibility study LONDON, UK / OSLO, NORWAY, July 06, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today announced that it is progressing a formal technical and commercial feasibility study for the integration of a battery energy storage system ("BESS") at its 41.5 MW Mo i

    7/6/26 3:00:00 PM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 10, 2021 - Coronavirus (COVID-19) Update: December 10, 2021

    For Immediate Release: December 10, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On December 9, 2021, the FDA updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to share the latest information. The update added new information about the Meridian Bioscience, Inc. Revogene SARS-CoV-2 test, inc

    12/10/21 1:56:40 PM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    SEC Filings

    View All

    SEC Form 6-K filed by VivoPower PLC

    6-K - VivoPower PLC (0001681348) (Filer)

    7/20/26 10:15:00 AM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form 6-K filed by VivoPower PLC

    6-K - VivoPower PLC (0001681348) (Filer)

    7/17/26 5:25:01 PM ET
    $VIVO
    Power Generation
    Utilities

    Amendment: SEC Form 6-K/A filed by VivoPower PLC

    6-K/A - VivoPower PLC (0001681348) (Filer)

    7/7/26 5:25:36 PM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HC Wainwright & Co. reiterated coverage on Meridian Bioscience with a new price target

    HC Wainwright & Co. reiterated coverage of Meridian Bioscience with a rating of Buy and set a new price target of $30.00 from $28.00 previously

    2/7/22 6:13:53 AM ET
    $VIVO
    Power Generation
    Utilities

    HC Wainwright & Co. reiterated coverage on Meridian Bioscience with a new price target

    HC Wainwright & Co. reiterated coverage of Meridian Bioscience with a rating of Buy and set a new price target of $28.00 from $27.00 previously

    11/15/21 6:32:31 AM ET
    $VIVO
    Power Generation
    Utilities

    HC Wainwright & Co. reiterated coverage on Meridian Bioscience with a new price target

    HC Wainwright & Co. reiterated coverage of Meridian Bioscience with a rating of Buy and set a new price target of $27.00 from $30.00 previously

    8/9/21 6:33:26 AM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Financials

    Live finance-specific insights

    View All

    Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction

    Shareholders to Receive $34.00 Per Share in Cash, Providing Immediate, Compelling and Certain Value Transaction Follows Deliberate Review, Including Outreach to Potential Strategic and Financial Partners CINCINNATI and SEOUL, South Korea, July 7, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD Biosensor, Inc. ("SDB") (KOSE: A137310) and SJL Partners LLC ("SJL") (collectively, the "Consortium") announced today that they have entered into a definitive merger agreement whereby a newly formed affiliate vehicle of the Consortium will acquire Meridian in an a

    7/7/22 7:17:00 AM ET
    $VIVO
    Power Generation
    Utilities

    MERIDIAN BIOSCIENCE REPORTS RECORD SECOND QUARTER FISCAL 2022 OPERATING RESULTS

    CINCINNATI, May 6, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced financial results for the second quarter ended March 31, 2022. Second Quarter Fiscal 2022 Highlights (Comparison to Second Quarter Fiscal 2021): Consolidated net revenues totaled $111.2 million, the highest in Company history, with both segments ahead of expectationsLife Science segment delivered record net revenues of $70.1 millionDiagnostics segment net revenues increased 29% year-over-year to a record $41.1 millionLaunched Lyo-Ready™ sample specific master mixes for bloodResumed

    5/6/22 8:00:00 AM ET
    $VIVO
    Power Generation
    Utilities

    Meridian Acquires EUPROTEIN to Further Expand Recombinant Protein Capabilities

    CINCINNATI, Ohio, May 2, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc.  The transaction closed on April 30, 2022. EUPROTEIN Inc. offers custom development and production of high-quality bioresearch reagents, with a particular focus on human and other mammalian proteins and recombinant monoclonal antibodies.  This acquisition will help

    5/2/22 8:47:00 AM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Leadership Updates

    Live Leadership Updates

    View All

    VivoPower Appoints Group Finance Director

    LONDON, UK / ABU DHABI, UAE, July 20, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today announced the appointment of Syed Muhammad Nouman, FCA, as Group Finance Director, effective from July 20, 2026. Mr. Nouman will serve as the Company’s Principal Financial Officer and Principal Accounting Officer for SEC reporting purposes, as ratified by the Company’s Audit Committee. Mr. Nouman began his career at PwC, where he developed a strong foundation in audit and financial reporting. He is a Fellow Chartered Accountant (FCA) with mor

    7/20/26 9:00:00 AM ET
    $VIVO
    Power Generation
    Utilities

    VivoPower Reinforces Focus on AI Data Center Business and Provides Update on Non-Core Businesses

    LONDON, UNITED KINGDOM, July 02, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today provides the following update in respect of its strategic direction and the previously announced separation initiatives relating to its subsidiaries Tembo e-LV B.V. ("Tembo") and Caret Digital ("Caret Digital"). Following a strategic review, the Board of Directors of the Company has determined that VivoPower will focus, as a group and as its principal strategic priority, on the development and scale-up growth of its AI data center business and that

    7/2/26 5:25:00 PM ET
    $VIVO
    Power Generation
    Utilities

    VivoPower's B Corporation Recertification Strengthens Its Sovereign Infrastructure Mandate; Tembo Qualified to Use B Corp Logo

    VivoPower's recertification extends its continuous B Corp status to 2028, eight years after its initial certification in April 2018 The recertification provides verified third-party assurance of VivoPower's governance, environmental, and stakeholder accountability standards as the Company scales its sovereign AI data center platform across the Nordics, Western Europe, and the Middle East Tembo Group has qualified under B Lab's brand review process to use the B Corp logo on its website, in addition to VivoPower's own continued use of the logo LONDON, June 16, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner

    6/16/26 8:15:00 AM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Meridian Bioscience Inc. (Amendment)

    SC 13G/A - MERIDIAN BIOSCIENCE INC (0000794172) (Subject)

    2/9/23 11:27:43 AM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form SC 13D/A filed by Meridian Bioscience Inc. (Amendment)

    SC 13D/A - MERIDIAN BIOSCIENCE INC (0000794172) (Subject)

    2/3/23 2:06:19 PM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form SC 13G/A filed by Meridian Bioscience Inc. (Amendment)

    SC 13G/A - MERIDIAN BIOSCIENCE INC (0000794172) (Subject)

    1/31/23 11:06:04 AM ET
    $VIVO
    Power Generation
    Utilities